Longevity medicine, long the turf of pricey boutique clinics, is moving into major academic health systems. That may bring more scientific credibility, but the hospitals draw their lines in different places, and critics say weakly proven tests belong in research rather than paid care.
From boutique clinics to big hospitals
Longevity medicine aims to extend both lifespan and healthspan, the years lived without chronic disease or disability. The United States has hundreds of boutique clinics offering it. Until recently, they sat outside mainstream medicine, charged thousands to tens of thousands of dollars a year, and often sold screenings and treatments not yet proven to work. According to a New York Times report by Eilene Zimmerman, several large health systems have now opened their own programs, including Northwestern, Mount Sinai, Weill Cornell and Cedars-Sinai.
Why patients choose them
For patients, the draw is accountability. Kathleen Wood, 66, lost both parents before age 62. She said she wanted her care backed by medical research, so she chose Northwestern Medicine’s clinic over a boutique one. The program costs $5,500 a year, and across these hospital programs, packages run from about $5,500 to $12,000. Insurers generally do not pay for them.
Where the hospitals draw the line
For comparison, one boutique company, Fountain Life, charges $23,500 a year at its top tier. For that, members can get whole genome sequencing, whole-body MRI, stem cell therapies and plasma exchange. Its chief medical officer says some of these have early, promising data and that much of the important science lies between “proven” and “worthless.”
The hospitals disagree with one another:
- Northwestern: It combines well-established measures such as VO2 max testing with less-validated ones, such as biological age tests. But it refuses whole-body MRI and genome sequencing. Its medical director, Dr. Baljash Cheema, said the clinic knows it loses some wealthy customers this way, but holds a firm line.
- Mount Sinai and Weill Cornell: They offer whole-body MRI and genetic tests, either optionally or after a risk consultation. Such scans can cause false alarms and needless anxiety.
- Cedars-Sinai: It tries to keep the field from becoming a privilege of the wealthy. Basic tests are billed to insurance, and experimental ones are offered through research programs.
The ethical criticism
Experts warn that the hospitals’ move is partly driven by market pressure. They argue that tests with weak evidence belong in clinical research, not in paid care.
What to keep in mind
A hospital name is not proof that every test is useful. The programs differ widely in what they include, and what counts as “validated” is exactly what the hospitals disagree about. Anyone considering such a program could ask which tests have evidence of improving outcomes, and what a false alarm would lead to.
Source: Many hospitals embrace longevity medicine. Are they separating science from hype?, The New York Times, October 16, 2026, by Eilene Zimmerman.
Transparency Note: This article was prepared with the assistance of artificial intelligence technologies. Every piece is thoroughly reviewed and verified by our editorial team, who retain full responsibility for the final content.
Medical Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute medical or therapeutic advice. Always seek the advice of a qualified healthcare professional with any questions you may have regarding a medical condition or treatment.